NM_001145026.2:c.6454-185T>G

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_001145026.2(PTPRQ):​c.6454-185T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.167 in 152,136 control chromosomes in the GnomAD database, including 2,839 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.17 ( 2839 hom., cov: 32)

Consequence

PTPRQ
NM_001145026.2 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -1.09

Publications

1 publications found
Variant links:
Genes affected
PTPRQ (HGNC:9679): (protein tyrosine phosphatase receptor type Q) This locus encodes a member of the type III receptor-like protein-tyrosine phosphatase family. The encoded protein catalyzes the dephosphorylation of phosphotyrosine and phosphatidylinositol and plays roles in cellular proliferation and differentiation. Mutations at this locus have been linked to autosomal recessive deafness. [provided by RefSeq, Mar 2014]
PTPRQ Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 84A
    Inheritance: AR, SD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • hearing loss, autosomal dominant 73
    Inheritance: AD, Unknown Classification: MODERATE, LIMITED Submitted by: PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 12-80670159-T-G is Benign according to our data. Variant chr12-80670159-T-G is described in ClinVar as Benign. ClinVar VariationId is 1280250.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.239 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PTPRQNM_001145026.2 linkc.6454-185T>G intron_variant Intron 41 of 44 ENST00000644991.3 NP_001138498.1 A0A087WZU1
LOC105369867XR_007063388.1 linkn.130+36950A>C intron_variant Intron 1 of 4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PTPRQENST00000644991.3 linkc.6454-185T>G intron_variant Intron 41 of 44 NM_001145026.2 ENSP00000495607.1 A0A087WZU1
PTPRQENST00000616559.4 linkc.6553-185T>G intron_variant Intron 41 of 44 5 ENSP00000483259.1 A0A087X0B9
ENSG00000304204ENST00000801015.1 linkn.100+36950A>C intron_variant Intron 1 of 2
ENSG00000304204ENST00000801016.1 linkn.101-17808A>C intron_variant Intron 1 of 1

Frequencies

GnomAD3 genomes
AF:
0.167
AC:
25382
AN:
152018
Hom.:
2839
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0423
Gnomad AMI
AF:
0.133
Gnomad AMR
AF:
0.114
Gnomad ASJ
AF:
0.204
Gnomad EAS
AF:
0.0334
Gnomad SAS
AF:
0.205
Gnomad FIN
AF:
0.292
Gnomad MID
AF:
0.187
Gnomad NFE
AF:
0.242
Gnomad OTH
AF:
0.159
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.167
AC:
25371
AN:
152136
Hom.:
2839
Cov.:
32
AF XY:
0.167
AC XY:
12432
AN XY:
74364
show subpopulations
African (AFR)
AF:
0.0422
AC:
1753
AN:
41556
American (AMR)
AF:
0.114
AC:
1734
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.204
AC:
710
AN:
3472
East Asian (EAS)
AF:
0.0331
AC:
171
AN:
5162
South Asian (SAS)
AF:
0.203
AC:
981
AN:
4822
European-Finnish (FIN)
AF:
0.292
AC:
3085
AN:
10582
Middle Eastern (MID)
AF:
0.190
AC:
56
AN:
294
European-Non Finnish (NFE)
AF:
0.242
AC:
16423
AN:
67964
Other (OTH)
AF:
0.160
AC:
337
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1043
2085
3128
4170
5213
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
300
600
900
1200
1500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.196
Hom.:
435
Bravo
AF:
0.148
Asia WGS
AF:
0.0960
AC:
336
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Dec 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
0.42
DANN
Benign
0.71
PhyloP100
-1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10506831; hg19: chr12-81063938; API